Our results also showed that miR‐30a‐5p regulated gut microbiota through ALOX5, ALOX12 and COX2 – key enzymes of the arachidonic acid pathway – affecting hepatic steatosis and dyslipidaemia in mice. Here, ALOX5 is linked to fatty liver disease.